TOP STORIES

• REGULATORY Japan Sees Delay in Pilot-Based Revenue Assurance System for Antibiotics, Criteria Still Up in Air
  August 9, 2023

• BUSINESS Astellas Puts Up US$50 Million for CAR-T Player Poseida
  August 9, 2023

• REGULATORY Approve 16 Pediatric Cancer Meds as Exceptional Step Beyond Law, Oncologist Urges
  August 8, 2023

• BUSINESS Shipment Restrictions Now Hit All Versions of Mounjaro in Japan
  August 8, 2023

• REGULATORY MHLW Panel to Review Alzheimer’s Med Lecanemab on August 21
  August 8, 2023

• COMMENTARY Study Group of LDP Heavyweights Eyes “Drug Discovery Agency”
  August 7, 2023

• REGULATORY Japan Adopts New Evaluation Method for Nitrosamine Impurities Risks
  August 7, 2023

• BUSINESS Mitsubishi Tanabe Aims to Maximize Value of Mounjaro through Synergies with Other Products
  August 4, 2023

• REGULATORY Chuikyo Reps Criticize Manufacturers’ Price Cuts after Unprofitability Re-Pricing
  August 3, 2023

• BUSINESS Japan OKs 1st Homemade COVID Jab, but No Supply Planned; Daiichi to Pursue XBB.1 Update
  August 3, 2023

• BUSINESS Astellas to Cut 500 More Jobs in Buyout Targeting Commercial Unit
  August 2, 2023

• REGULATORY Generics Panel Initiates Debate toward Proposing Stable Supply Measures, Interim Report Slated for October
  August 1, 2023

• REGULATORY Japan Panel Shelves Decision on Shionogi’s COVID Vaccine over Efficacy Data
  August 1, 2023

• ORGANIZATION IRA Could Create New Type of Drug Loss, Affecting Japan Too: PhRMA Official
  July 31, 2023

• REGULATORY Japan to Buy 20 Million Doses of Pfizer COVID Jab, 5 Million from Moderna
  July 28, 2023

• REGULATORY Japan Likely to Slash Moderna Vaccine Purchase, Pfizer Single-Sourcing Plan Nixed
  July 28, 2023

• REGULATORY Chuikyo Wary of Abolishing Spillover Rule, Positive on Reviewing Market Expansion Re-Pricing
  July 27, 2023

• REGULATORY Chuikyo Divided Over Raising Premium Rates for Listed Products, Extending Evaluation Data
  July 27, 2023

• BUSINESS After CAR-T Transfer, Gilead Sets Cell Therapy as Key Biz Pillar for Growth in Japan
  July 26, 2023

• REGULATORY MHLW Pharma Bureau Chief Eager to Do Everything on Regulation Panel’s Agenda
  July 25, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• …
• Next ›
• 最終 »